ATLANTA, GA--(Marketwire - May 06, 2008) - MIV Therapeutics, Inc. (OTCBB: MIVT) (FRANKFURT: MIV) (http://www.mivtherapeutics.com), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, was featured in Cardiovascular Business News, a newsweekly concerning cardiovascular medicine.
